A carregar...

Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related mortality and continues to increase. Current standard of care for patients with HCC only provides limited therapeutic benefit. Development of innovative strategies is urgently needed. Experience with immunotherapy in HCC is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Cell Immunol
Main Authors: Liu, Dai, Staveley-O’Carroll, Kevin F., Li, Guangfu
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4750497/
https://ncbi.nlm.nih.gov/pubmed/26877890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9899.1000376
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!